10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

49 Sudden Deaths, 213 Permanent Disabilities - And the Silent Plan to Poison Your Child

Story at-a-glance -

  • The HPV vaccine is NOT harmless like it is being promoted and has not been proven to actually prevent cervical cancer
  • The HPV vaccine only protects against TWO strains of HPV associated with cancer but there are MORE THAN 100 different strains of HPV in all.
  • Dr. Diane Harper, one of the lead researchers for Gardasil blew the whistle on the vaccine, saying the available data suggests the HPV vaccine's protective effects do not last beyond five years.
  • The VAERS database continues to swell with reports of autoimmune disorders contracted after receiving the HPV vaccine. These side effects now include 137 reports of cervical dysplasia, and 41 reports of cervical cancer.
  • HPV infection clears up on its own within two years in 90 percent of all cases. It rarely leads to cervical cancer unless the infection becomes chronic and leads to cervical changes that remain untreated. Routine pap smear testing can identify chronic HPV infection and may provide greater protection against development of cervical cancer than reliance on an HPV vaccine that has not been adequately proven to be safe or effective.

By Dr. Mercola

During a Republican debate in Tampa, Florida, presidential hopeful Michele Bachmann (R-Minnesota) alleged that campaign contributions from drug company Merck—the maker of Gardasil—played "a pivotal role in Rick Perry's 2007 executive order that mandated teenage girls in Texas be inoculated against HPV," CNN reports.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access